grant

Development of Novel antibacterial compounds from subtilosin A [ 2008 - 2011 ]

Also known as: Development of Novel antibacterial compounds

Funded by National Health and Medical Research Council
Managed by The University of Queensland
Managed by University of Queensland
Provided by   National Health and Medical Research Council

Research Grant

[Cite as https://purl.org/au-research/grants/nhmrc/519734]

Researchers: Prof David Craik (Principal investigator) ,  Prof Glenn King

Brief description We aim to overcome a problem that is not being addressed by pharmaceutical companies- i.e., there is an urgent need to develop new classes of antibacterial drugs because of the increasing prevalence of drug resistant bacteria. We will combine genetics, structural biology and chemistry to develop a new class of anti-bacterial drug based on a naturally occurring microbial molecule that is novel in structure and very stable- attributes that make it very different to existing therapeutic approaches.

Funding Amount $AUD 490,724.81

Funding Scheme NHMRC Project Grants

Notes Standard Project Grant

Click to explore relationships graph
Help

Related Organisations

Related People

Subjects
Antibiotics | Antimicrobial resistance | Antimicrobial therapy | Biomedical and Clinical Sciences | Bacterial Pathogens | Dentistry | Drug Design | Food borne infections | Food technology | Microbial infections | Microbiological safety | Oral and Maxillofacial Surgery | Structure-Activity Relationships |
Identifiers
Viewed: [[ro.stat.viewed]]
Saved to MyRDA Save to MyRDA